期刊文献+

靶向NAC-1基因的siRNA对卵巢癌HO8910细胞生长及其Wnt/β-catenin信号途径的影响 被引量:4

Effects of specific small interfering RNA against nucleus accumbens-1 gene on cell proliferation of ovarian cancer cells and Wnt / β-catenin signaling pathway
下载PDF
导出
摘要 目的 :研究NAC-1调节卵巢癌HO8910细胞生长增殖的机制。方法 NAC-1基因特异性小干扰RNA(siRNA)处理HO8910细胞,然后检测细胞增殖率、细胞周期、以及NAC-1蛋白、WNT信号途径β-链蛋白、低密度脂蛋白受体相关蛋白6(LRP6)基因及其下游靶基因cyclin D1和survivin基因表达。结果 NAC-1基因的特异性siRNA不仅显著抑制HO8910细胞中NAC-1 mRNA和蛋白的表达,明显抑制细胞增殖,细胞周期被阻滞于G1期,而且显著抑制其Wnt/β-catenin信号途径活性:转染48 h,β-catenin、cyclin D1、survivin蛋白水平显著下降,cyclin D1、survivin基因mRNA表达水平显著下降,与空白对照组相比较有显著差异(P<0.01)。结论 NAC-1通过调节β-catenin蛋白水平增强WNT信号途径活性、促进卵巢癌HO8910细胞增殖。 Objective To investigate the mechanism of nucleus accumbens-1(Nac1 or NAC-1)protein on the proliferation of ovarian cancer cell line HO8910. Methods Specific NAC-1 siRNAs and one negative siRNA were individually transfected into HO8910 cells for 48 h . Levels of NAC-1, β-catenin, LRP6, cyclinD1, and survivin mRNA and protein were analyzed by real-time fluorescence quantitative PCR (qRT-PCR) and Western blotting, respectively. The cell proliferation was determined by MTT assay and plate clone formation assay. The distribution of cell cycle was assessed by flow cytometry. Results After NAC-1 siRNA treatment for 48 h, not only the NAC-1 gene was silenced in HO8910 cells, the cell growth was inhibited, and cell cycle arrested in G1 phase, but also the activity of Wnt/β-catenin signaling decreased significantly, which levels of β-catenin, cyclinD1, and survivin proteins, cyclinD1 and survivin mRNA all decreased, as compared with the control groups, the difference was statistically significant. However, NAC-1 gene silencing in ovarian carcinoma cells HO8910 did not affect levels of p-LRP6 protein, LRP6 mRNA and β -catenin mRNA, as compared with the control groups, the difference was not statistically significant. Conclusion NAC-1 enhance the activity of WNT signaling pathway through the regulation of β -catenin protein level, promote ovarian cancer HO8910 cell proliferation.
出处 《基础医学与临床》 CSCD 北大核心 2013年第12期1581-1585,共5页 Basic and Clinical Medicine
基金 湖南省卫生厅科研计划(B2011-89)
关键词 NAC-1 SIRNA 卵巢癌 细胞增殖 细胞周期 WNT信号途径 Nucleus accumbens-1 small interfering RNA ovarian cancer Cell proliferation Cell cycle Wnt/β-catenin signaling
  • 相关文献

参考文献12

  • 1Nakayama K, Nakayama N, Wang TL, et al. NAC-1 con-trols cell growth and survival by repressing transcription ofGadd45GIPl, a candidate tumor suppressor [ J] . CancerRes, 2007, 67:8058 -8064.
  • 2Jinawath N, Vasoontara C, Yap KL,et al. NAC-1, a po-tential stem cell pluripotency factor, contributes to paclitax-el resistance in ovarian cancer through inactivating Gadd45pathway[ J]. Oncogene, 2009,28 : 1941 - 1948.
  • 3桂玲,王静,祝爱珍,刘成成,刘革修.特异siRNA下调卵巢癌H08910细胞NAC-1基因表达并抑制生长[J].基础医学与临床,2012,32(10):1221-1223. 被引量:3
  • 4Clevers H, Nusse R. Wnt/p-catenin signaling and disease[J]. Cell, 2012, 149:1192-1205.
  • 5Yao H, Ashihara E, Maekawa T, Targeting the Wnt/p-catenin signaling pathway in human cancers [ J]. ExpertOpin Ther Targets, 2011,15:873 -887.
  • 6Ferrandina G, Legge F, Martinelli E, et al. Survivin ex-pression in ovarian cancer and its correlation with clinico-pathological,surgical and apoptosis-related parameters[ J].Br J Cancer, 2005, 92:271 -277.
  • 7No JH, Jeon YT,Kim YB,et al. Quantitative detection ofserum survivin and its relationship with prognostic factors inovarian cancer [ J]. Gynecol Obstet Invest, 2011,71:136-140.
  • 8Vivas-Mejia PE, Rodriguez-Aguayo C,Han HD,et al. Si-lencing survivin splice variant 2B leads to antitumor activityin taxane-resistant ovarian cancer [ J]. Clin Cancer Res.2011,17:3716-3726.
  • 9Xing J, Jia CR, Wang Y,et al. Effect of shRNA targetingsurvivin on ovarian cancer[ J]. J Cancer Res Clin Oncol,2012, 138:1221 -1229.
  • 10Nakayama K,Nakayama N, Davidson B , et al. A BTB/POZ protein, NAC-1,is related to tumor recurrence and isessential for tumor growth and survival [ J]. Proc NatlAcad Sci USA, 2006, 103 : 18739 - 18744.

二级参考文献3

  • 1Hu L, McArthur C, Jaffe RB. Ovarian cancer stem-like side-population ceils are tumourigenic and chemoresistant [J]. Br J Cancer, 2010,102:1276 - 1283.
  • 2Kobayashi Y, Seino K, Hosonuma S, et al. Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin [ J ]. Gynecol Oncol,2011, 121:390 -394.
  • 3Ishibashi M, Nakayama K, Yeasmin S, et al. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer [ J ]. Chn Cancer Res, 2008, 14:3149 -3155.

共引文献2

同被引文献23

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部